Zynerba Pharmaceuticals Aktie

13,18 $ -3,37% -0,46 $
In Euro: 12,262 € | 05.12.16 Nasdaq | Mehr Kurse »
WKN: A14XCV
ISIN: US98986X1090
Symbol: ZYNE
Typ: Aktie

Performance Zynerba Pharmaceuticals Aktie

1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 13,24 $ 12,22 $ 9,45 $ 10,07 $ 12,96 $ -
Änderung -0,45% +7,86% +39,47% +30,88% +1,70% -

Forum zur Zynerba Pharmaceuticals Aktie

chinasky: ZYNE initiated Phase 2 clinical trail of CBD
07.09.16
Zitat:" Sept. 06, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-​stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that it has initiated ...

Aktie & Unternehmen

Branche Pharmazeutik
Herkunft USA
Website www.zynerba.com
Aktienanzahl 9,20 Mio. (Stand: 06.01.16)
Marktkap. 121,3 Mio. $

Dividenden & Splits

Keine Daten im genannten Zeitraum vorhanden

Ähnliche Aktien

Name
last
change_rel
 
KalVista Pharmaceuticals 6,772 € -9,37%
Dipexium Pharmaceuticals 1,255 € -0,95%
Cosmo Pharm 160,17 € -0,25%
Recro Pharma 6,563 € +9,38%
Inotek Pharmaceuticals 6,23 € +4,86%